Sudarshan Hebbar
Technik-/Wissenschafts-/F&E-Leiter bei CALCIMEDICA, INC.
Vermögen: 261 280 $ am 31.05.2024
Aktive Positionen von Sudarshan Hebbar
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CALCIMEDICA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2017 | - |
| Corporate Officer/Principal | 01.11.2015 | 01.04.2017 |
Karriereverlauf von Sudarshan Hebbar
Ehemalige bekannte Positionen von Sudarshan Hebbar
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCIMMUNE HOLDINGS PLC | Direktor/Vorstandsmitglied | 01.07.2013 | 01.10.2013 |
| Corporate Officer/Principal | 01.07.2013 | 01.10.2013 | |
| REATA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2011 | 01.12.2012 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.08.2007 | 01.07.2011 |
| Kidney Associates of Kansas City PC | Corporate Officer/Principal | 01.01.1995 | 01.01.2007 |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - | - |
Ausbildung von Sudarshan Hebbar
| The Johns Hopkins University | Undergraduate Degree |
| Tulane University School of Medicine | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Kanada | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 7 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ONCIMMUNE HOLDINGS PLC | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
| Kidney Associates of Kansas City PC |
- Börse
- Insiders
- Sudarshan Hebbar
- Erfahrung